CIK 0001119774 · Accelerated filer
COMPUGEN LTD
Sign in to watch- Ticker
- CGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 011-972-3-765-8585
- Business address
- 26 HAROKMIM STREET, BUILDING D, HOLON, Israel, 5885849
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-29 | Levine Zurit SVP, Business Development | Grant or award | +18,000 | 47,375 | ||
| 2026-07-29 | Levine Zurit SVP, Business Development | Grant or award · Share Option (right to buy) | +24,000 | 24,000 | ||
| 2026-07-29 | Silberman David Chief Financial Officer | Grant or award | +19,500 | 55,000 | ||
| 2026-07-29 | Silberman David Chief Financial Officer | Grant or award · Share Option (right to buy) | +26,000 | 26,000 | ||
| 2026-07-29 | Ophir Eran President and CEO | Grant or award · Share Option (right to buy) | +200,000 | 200,000 | ||
| 2026-07-29 | Cohen-Dayag Anat Director | Grant or award · Share Option (right to buy) | +100,000 | 100,000 | ||
| 2026-07-29 | Perry Eran Director | Grant or award | +7,500 | 17,500 | ||
| 2026-07-29 | Perry Eran Director | Grant or award · Share Option (right to buy) | +10,000 | 10,000 | ||
| 2026-07-29 | Ferre Pierre Chief Operating Officer | Grant or award · Share Option (right to buy) | +70,000 | 70,000 | ||
| 2026-07-29 | Kredo Russo Sharon SVP, Research & Discovery | Grant or award | +18,000 | 37,500 | ||
| 2026-07-29 | Kredo Russo Sharon SVP, Research & Discovery | Grant or award · Share Option (right to buy) | +24,000 | 24,000 | ||
| 2026-07-29 | Livnat Savitzky Kinneret Director | Grant or award | +7,500 | 20,850 | ||
| 2026-07-29 | Livnat Savitzky Kinneret Director | Grant or award · Share Option (right to buy) | +10,000 | 10,000 | ||
| 2026-07-29 | Hukkelhoven Mathias Director | Grant or award | +7,500 | 17,500 | ||
| 2026-07-29 | Hukkelhoven Mathias Director | Grant or award · Share Option (right to buy) | +10,000 | 10,000 | ||
| 2026-07-29 | Halevy Gilead Director | Grant or award | +7,500 | 18,907 | ||
| 2026-07-29 | Halevy Gilead Director | Grant or award · Share Option (right to buy) | +10,000 | 10,000 | ||
| 2026-07-29 | ZWEIFACH SANFORD S Director | Grant or award | +7,500 | 20,180 | ||
| 2026-07-29 | ZWEIFACH SANFORD S Director | Grant or award · Share Option (right to buy) | +10,000 | 10,000 | ||
| 2026-07-29 | Mahler Michelle Chief Medical Officer | Grant or award | +13,500 | 36,625 |
Page 1 of 4 · 65 trades